Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

Oprah Winfrey confessed that she previously believed thin people had immense “willpower” and that they “never had a potato ...

An anxious generation turns to functional foods and beverages and alternative medicine, inspiring better-for-you innovation.

Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight ...

The readout comes on the heels of CagriSema’s disappointing Phase III performance, where it missed Novo’s projection of 25% ...

Oprah Winfrey reflects on past misconceptions about weight, admitting that a GLP-1 drug shifted her perspective.

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.

The company emphasised that it is ready to meet the growing demand for drug-device combinations and biologics, with ...

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Oprah Winfrey has admitted to using an unnamed weight-loss drug to manage her weight and says doing so has changed her ...

Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...